港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

工業大麻

378.297

+8.9372.42%

漲家數：2

跌家數：4

平家數：1

市盈率：- -

高：383.050

開：369.360

低：368.734

收：369.360

資料載入中...

四環醫藥04月11日獲主力加倉491萬元

先健科技04月11日獲主力加倉444萬元

中國碳中和04月11日主力淨流出23萬元散户資金買入

四環醫藥盤中漲超6% 旗下創新藥吡洛西利聯合氟維司羣療效顯著

港股異動 | 四環醫藥(00460)盤中漲超6% 附屬軒竹生物治療晚期乳腺癌藥物臨牀研究顯示突出生存數據

訓修實業盤中異動早盤大幅跳水5.15%

雲白國際盤中異動早盤股價大跌7.63%

四環醫藥盤中異動早盤股價大漲6.56%

四環醫藥(00460)出現大手買入300萬股，成交價$0.63，涉資189萬

阿斯达克财经

四環醫藥04月10日獲主力加倉124萬元

先健科技04月10日主力淨流入57萬元散户資金拋售

四環醫藥附屬公司吡洛西利臨牀研究成果登《Nature Communications》

中國碳中和盤中異動急速下挫5.26%

四環醫藥(00460)：吡洛西利聯合氟維司羣治療HR+╱HER2-晚期乳腺癌臨牀III期期中分析結果刊登Nature子刊

美瑞健康國際盤中異動下午盤快速拉昇5.56%

【四環醫藥(00460.HK)：創新藥吡洛西利聯合氟維司羣治療HR+/HER2-晚期乳腺癌臨牀III期期中分析結果在《Nature Communications》學術期刊發表】四環醫藥(00460.HK)發佈公告，本集團旗下非全資附屬公司軒竹生物科技股份有限公司(軒竹生物)研發的創新藥吡洛西利(Bireociclib)取得了重大科研突破，其聯合氟維司羣治療HR+/HER2-晚期乳腺癌臨牀III期研究( BRIGHT-2，NCT05077449)期中分析結果，已正式刊登於頂級期刊Nature子刊《Nature Communications》。

四環醫藥(00460.HK)：軒竹生物研發的創新藥吡洛西利聯合氟維司羣治療HR+╱HER2-晚期乳腺癌臨牀III期期中分析結果在《Nature Communications》學術期刊發表

四環醫藥(00460.HK)附屬治療晚期乳腺癌藥物臨牀研究顯示突出生存數據

阿斯达克财经

先健科技盤中異動早盤急速上漲5.15%

四環醫藥盤中異動早盤股價大漲5.08%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1600/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1600","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1600\",,,,,undefined,":{"symbol":"BK1600","market":"HK","secType":"PLATE","nameCN":"工業大麻","latestPrice":378.2968,"timestamp":1744358897778,"preClose":369.36014,"halted":0,"volume":71400000,"delay":0,"changeRate":0.024195,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":8.936676,"latestTime":"04-11 16:00:00","open":369.36014,"high":383.0495,"low":368.73425,"amount":54129536,"amplitude":0.038757,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1744594200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1744335000000,1744344000000],[1744347600000,1744358400000]],"pbRate":1.375738,"peRate":647.432609,"turnoverRate":0.002567,"increases":2,"decrements":4,"flats":1,"marketCap":15083405232,"floatMarketCap":15083556848},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1600\",,,,,undefined,":{"symbol":"BK1600","high":383.0495,"amplitude":0.038757,"preClose":369.36014,"low":368.73425,"pbRate":"1.375738","latestPrice":378.2968,"volume":71400000,"delay":0,"open":369.36014,"prevYearClose":390.2235,"prevWeekClose":400.768,"prevMonthClose":386.19,"prevQuarterClose":386.19,"fiveDayClose":400.768,"twentyDayClose":388.714,"sixtyDayClose":362.572,"secType":"PLATE","market":"HK","turnoverRate":0.002567,"peRate":647.432609,"marketCap":15083405232,"floatMarketCap":15083556848,"timestamp":1744358897778,"nameCN":"工業大麻"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1600\",,,,undefined,":{"bkCode":"BK1600","up":2,"down":4,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1600\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2526558206","title":"四環醫藥04月11日獲主力加倉491萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526558206","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526558206?lang=zh_tw&edition=fundamental","pubTime":"2025-04-11 16:17","pubTimestamp":1744359435,"startTime":"0","endTime":"0","summary":"04月11日, 四环医药股价涨3.28%，报收0.63元，成交金额2648万元，换手率0.45%，振幅6.56%，量比0.77。四环医药今日主力资金净流入491万元，连续3日净流入，上一交易日主力净流入124万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为62.50%，平均涨幅为3.87%。该股近5个交易日下跌4.55%，主力资金累计净流入584万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入3569万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411171139a455f64f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411171139a455f64f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","BK1600","00460","BK1593"],"gpt_icon":0},{"id":"2526632237","title":"先健科技04月11日獲主力加倉444萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526632237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526632237?lang=zh_tw&edition=fundamental","pubTime":"2025-04-11 16:16","pubTimestamp":1744359361,"startTime":"0","endTime":"0","summary":"04月11日, 先健科技股价涨3.62%，报收1.43元，成交金额2521万元，换手率0.39%，振幅4.35%，量比0.55。先健科技今日主力资金净流入444万元，上一交易日主力净流入57万元。该股近5个交易日下跌9.43%，主力资金累计净流入647万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入1769万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411170501a6b795d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411170501a6b795d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1600","01302","BK1583","BK1100"],"gpt_icon":0},{"id":"2526632257","title":"中國碳中和04月11日主力淨流出23萬元 散户資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2526632257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526632257?lang=zh_tw&edition=fundamental","pubTime":"2025-04-11 16:15","pubTimestamp":1744359341,"startTime":"0","endTime":"0","summary":"04月11日，中国碳中和股价收平报0.28元，成交金额156万元，换手率0.90%，振幅5.45%，量比1.20。中国碳中和今日主力资金净流出23万元，上一交易日主力净流出0万元。该股近5个交易日下跌9.84%，主力资金累计净流出21万元；近20日主力资金累计净流出27万元，其中净流出天数为3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411170310a455f336&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411170310a455f336&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01372","BK1594","BK1144","BK1600"],"gpt_icon":0},{"id":"2526950841","title":"四環醫藥盤中漲超6% 旗下創新藥吡洛西利聯合氟維司羣療效顯著","url":"https://stock-news.laohu8.com/highlight/detail?id=2526950841","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526950841?lang=zh_tw&edition=fundamental","pubTime":"2025-04-11 11:23","pubTimestamp":1744341809,"startTime":"0","endTime":"0","summary":"四环医药盘中涨超6%，截至发稿，股价上涨3.28%，现报0.63港元，成交额1086.69万港元。四环医药公布，旗下非全资附属轩竹生物研发的创新药“吡洛西利”取得重大科研突破，其联合氟维司群治疗HR+╱HER2-晚期乳腺癌临床III期研究期中分析结果，已正式刊登于顶级期刊Nature子刊《Nature Communications》。公告称，吡洛西利联合氟维司群疗效显著。尤其是内分泌原发耐药、单纯骨转移、肝转移患者风险降低明显，并能使肿瘤缩小，缓解症状，带来生存获益。在本次研究中，吡洛西利面对人群更复杂、疾病更难治的挑战，依然获得突出生存数据。\n\n\r\n            责任编辑：栎树","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2025/04/11112349483435.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1574","00460","159992","BK1593","06978","BK1515","BK1191","BK1600","BK1161"],"gpt_icon":0},{"id":"2526772265","title":"港股異動 | 四環醫藥(00460)盤中漲超6% 附屬軒竹生物治療晚期乳腺癌藥物臨牀研究顯示突出生存數據","url":"https://stock-news.laohu8.com/highlight/detail?id=2526772265","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526772265?lang=zh_tw&edition=fundamental","pubTime":"2025-04-11 10:58","pubTimestamp":1744340314,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，四环医药(00460)盘中涨超6%，截至发稿，涨4.92%，报0.64港元，成交额1041.81万港元。消息面上，四环医药公布，旗下非全资附属轩竹生物研发的创新药“吡洛西利”取得重大科研突破，其联合氟维司群治疗HR+╱HER2-晚期乳腺癌临床III期研究期中分析结果，已正式刊登于顶级期刊Nature子刊《Nature Communications》。公告称，吡洛西利联合氟维司群疗效显著。尤其是内分泌原发耐药、单纯骨转移、肝转移患者风险降低明显，并能使肿瘤缩小，缓解症状，带来生存获益。在本次研究中，吡洛西利面对人群更复杂、疾病更难治的挑战，依然获得突出生存数据。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1277227.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","00460","BK1600","BK1593","BK1515"],"gpt_icon":0},{"id":"2526589505","title":"訓修實業盤中異動 早盤大幅跳水5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526589505","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526589505?lang=zh_tw&edition=fundamental","pubTime":"2025-04-11 10:40","pubTimestamp":1744339224,"startTime":"0","endTime":"0","summary":"2025年04月11日早盘10时40分，训修实业股票出现异动，股价急速下挫5.15%。截至发稿，该股报0.460港元/股，成交量5.2万股，换手率0.01%，振幅0.00%。训修实业股票所在的其他服饰配件行业中，整体涨幅为0.55%。其相关个股中，盈利时、中联发展控股、普拉达涨幅较大，振幅较大的相关个股有恒发光学、普拉达、新秀丽，振幅分别为10.40%、7.11%、5.83%。假发、假发配件及其他业务分部主要涉及售予美国及欧洲客户的一系列假发及其他假发配件。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411104024a455aaf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411104024a455aaf1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01962","BK1585","BK1207","BK1600"],"gpt_icon":0},{"id":"2526572470","title":"雲白國際盤中異動 早盤股價大跌7.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526572470","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526572470?lang=zh_tw&edition=fundamental","pubTime":"2025-04-11 10:38","pubTimestamp":1744339080,"startTime":"0","endTime":"0","summary":"2025年04月11日早盘10时38分，云白国际股票出现波动，股价快速跳水7.63%。截至发稿，该股报0.121港元/股，成交量92.4万股，换手率0.01%，振幅6.87%。资金方面，该股资金流入0港元，流出11.4862万港元。云白国际股票所在的食品添加剂行业中，整体跌幅为0.06%。其相关个股中，味丹国际、华宝国际、老恒和酿造涨幅较大，振幅较大的相关个股有味丹国际、绿新亲水胶体、颐海国际，振幅分别为3.23%、2.78%、2.69%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411103800a455aa49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411103800a455aa49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00030","BK1121","BK1600"],"gpt_icon":0},{"id":"2526579174","title":"四環醫藥盤中異動 早盤股價大漲6.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526579174","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526579174?lang=zh_tw&edition=fundamental","pubTime":"2025-04-11 10:08","pubTimestamp":1744337323,"startTime":"0","endTime":"0","summary":"2025年04月11日早盘10时08分，四环医药股票出现异动，股价大幅上涨6.56%。截至发稿，该股报0.650港元/股，成交量1230.1万股，换手率0.13%，振幅6.56%。四环医药股票所在的药品行业中，整体涨幅为0.11%。其相关个股中，长江生命科技、四环医药、东阳光长江药业涨幅较大，振幅较大的相关个股有长江生命科技、三生制药、德琪医药-B，振幅分别为16.67%、10.02%、8.64%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041110084494d25fc7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041110084494d25fc7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00460","BK1191","BK1515","BK1600","BK1593"],"gpt_icon":0},{"id":"2526157100","title":"四環醫藥(00460)出現大手買入300萬股，成交價$0.63，涉資189萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2526157100","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526157100?lang=zh_tw&edition=fundamental","pubTime":"2025-04-11 10:05","pubTimestamp":1744337100,"startTime":"0","endTime":"0","summary":"[大手成交]四环医药(00460)在上午10:05出现大手买入，成交量为300万，成交价为港币$0.63，涉资189万。至目前为止，股价升3.279%，今日最高价为$0.63，而最低价为$0.61，总成交量为851.3万股，总成交金额港币$530.162万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908460_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908460_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2504114642/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","BK1515","BK1593","00460","BK1600"],"gpt_icon":0},{"id":"2526532833","title":"四環醫藥04月10日獲主力加倉124萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526532833","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526532833?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 16:16","pubTimestamp":1744273018,"startTime":"0","endTime":"0","summary":"04月10日, 四环医药股价涨3.39%，报收0.61元，成交金额2644万元，换手率0.47%，振幅5.08%，量比0.71。四环医药今日主力资金净流入124万元，上一交易日主力净流入281万元。该股近5个交易日下跌7.58%，主力资金累计净流入517万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入2728万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410171151a454b97e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410171151a454b97e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1600","BK1191","BK1593","00460","BK1515"],"gpt_icon":0},{"id":"2526806539","title":"先健科技04月10日主力淨流入57萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2526806539","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526806539?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 16:15","pubTimestamp":1744272933,"startTime":"0","endTime":"0","summary":"04月10日, 先健科技股价涨1.47%，报收1.38元，成交金额2695万元，换手率0.42%，振幅4.41%，量比0.62。先健科技今日主力资金净流入57万元，上一交易日主力净流出82万元。该股近5个交易日下跌16.46%，主力资金累计净流出285万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入904万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410170308a6b65efa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410170308a6b65efa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01302","BK1583","BK1100","BK1600"],"gpt_icon":0},{"id":"2526588451","title":"四環醫藥附屬公司吡洛西利臨牀研究成果登《Nature Communications》","url":"https://stock-news.laohu8.com/highlight/detail?id=2526588451","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526588451?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 14:36","pubTimestamp":1744267008,"startTime":"0","endTime":"0","summary":"4月10日，四环医药（00460）发布公告，宣布其非全资附属公司轩竹生物研发的创新药吡洛西利在联合氟维司群治疗HR+/HER2-晚期乳腺癌的临床III期研究（BRIGHT-2）的期中分析结果已正式刊登于顶级期刊Nature子刊《NatureCommunications》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504103373053871.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["00460","BK1191","BK1593","BK1515","BK1600"],"gpt_icon":0},{"id":"2526301895","title":"中國碳中和盤中異動 急速下挫5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526301895","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526301895?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 13:23","pubTimestamp":1744262617,"startTime":"0","endTime":"0","summary":"2025年04月10日下午盘13时23分，中国碳中和股票出现波动，股价急速下挫5.26%。截至发稿，该股报0.270港元/股，成交量295.7万股，换手率0.46%，振幅7.02%。中国碳中和股票所在的重型基建行业中，整体涨幅为0.03%。其相关个股中，广骏集团控股、TBKS HLDGS、荣利营造涨幅较大，振幅较大的相关个股有中国红包、创业集团控股、宏基集团控股，振幅分别为16.43%、15.22%、11.84%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410132337aa2c68b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410132337aa2c68b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1144","01372","BK1600","BK1594"],"gpt_icon":0},{"id":"2526818309","title":"四環醫藥(00460)：吡洛西利聯合氟維司羣治療HR+╱HER2-晚期乳腺癌臨牀III期期中分析結果刊登Nature子刊","url":"https://stock-news.laohu8.com/highlight/detail?id=2526818309","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526818309?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 13:11","pubTimestamp":1744261912,"startTime":"0","endTime":"0","summary":"金吾财讯 | 四环医药 公告，集团旗下非全资附属公司轩竹生物科技股份有限公司研发的创新药吡洛西利取得了重大科研突破，其联合氟维司群治疗HR+╱HER2-晚期乳腺癌临床III期研究期中分析结果，已正式刊登于顶级期刊Nature子刊《Nature Communications》。在此次试验里，吡洛西利联合氟维司群疗效显着。中位随访8.7个月时，联合组中位PFS达12.94个月，远超氟维司群组的7.29个月。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210810/YWMzMDYxNjliM2VjNmQwMDUwODkzNDE4MTMw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/YWMzMDYxNjliM2VjNmQwMDUwODkzNDE4MTMw.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1956967","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4134","BK1515","BK4203","BK1191","00460","III","HR","BK1593","BK4225","BK1600"],"gpt_icon":0},{"id":"2526018103","title":"美瑞健康國際盤中異動 下午盤快速拉昇5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526018103","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526018103?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 13:11","pubTimestamp":1744261879,"startTime":"0","endTime":"0","summary":"2025年04月10日下午盘13时11分，美瑞健康国际股票出现波动，股价大幅拉升5.56%。截至发稿，该股报0.285港元/股，成交量187.8万股，换手率0.05%，振幅5.56%。美瑞健康国际股票所在的综合企业行业中，整体涨幅为0.40%。美瑞健康国际公司简介：美瑞健康国际产业集团有限公司是一家投资控股公司,主要从事买卖保健产品、化学材料及建筑材料业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410131119aa2c68b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410131119aa2c68b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1600","02327","BK1124"],"gpt_icon":0},{"id":"2526330688","title":"【四環醫藥(00460.HK)：創新藥吡洛西利聯合氟維司羣治療HR+/HER2-晚期乳腺癌臨牀III期期中分析結果在《Nature Communications》學術期刊發表】四環醫藥(00460.HK)發佈公告，本集團旗下非全資附屬公司軒竹生物科技股份有限公司(軒竹生物)研發的創新藥吡洛西利(Bireociclib)取得了重大科研突破，其聯合氟維司羣治療HR+/HER2-晚期乳腺癌臨牀III期研究( BRIGHT-2，NCT05077449)期中分析結果，已正式刊登於頂級期刊Nature子刊《Nature Communications》。","url":"https://stock-news.laohu8.com/highlight/detail?id=2526330688","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526330688?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 12:49","pubTimestamp":1744260552,"startTime":"0","endTime":"0","summary":"四环医药(00460.HK)发布公告，本集团旗下非全资附属公司轩竹生物科技股份有限公司(轩竹生物)研发的创新药吡洛西利(Bireociclib)取得了重大科研突破，其联合氟维司群治疗HR+/HER2-晚期乳腺癌临床III期研究( BRIGHT-2，NCT05077449)期中分析结果，已正式刊登于顶级期刊Nature子刊《Nature Communications》。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/10124949451016.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1191","BK4134","06978","159992","III","HR","BK4203","BK1515","00460","159837","BK4225","BK1574","BK1161","BK1600","BK1593"],"gpt_icon":0},{"id":"2526730595","title":"四環醫藥(00460.HK)：軒竹生物研發的創新藥吡洛西利聯合氟維司羣治療HR+╱HER2-晚期乳腺癌臨牀III期期中分析結果在《Nature Communications》學術期刊發表","url":"https://stock-news.laohu8.com/highlight/detail?id=2526730595","media":"格隆汇","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526730595?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 12:34","pubTimestamp":1744259687,"startTime":"0","endTime":"0","summary":"格隆汇4月10日丨四环医药宣布，集团旗下非全资附属公司轩竹生物科技股份有限公司研发的创新药吡洛西利取得了重大科研突破，其联合氟维司群治疗HR+╱HER2-晚期乳腺癌临床III期研究期中分析结果，已正式刊登于顶级期刊Nature子刊《Nature Communications》。研究从国内64个中心招募305例经内分泌治疗后进展的HR+╱HER2-晚期乳腺癌患者。在此次试验里，吡洛西利联合氟维司群疗效显著。中位随访8.7个月时，联合组中位PFS达12.94个月，远超氟维司群组的7.29个月。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/10123449450866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4134","HR","BK1161","159992","BK1191","BK1515","00460","BK1593","BK1600","06978","BK1574","BK4203","BK4225","III"],"gpt_icon":0},{"id":"2526305835","title":"四環醫藥(00460.HK)附屬治療晚期乳腺癌藥物臨牀研究顯示突出生存數據","url":"https://stock-news.laohu8.com/highlight/detail?id=2526305835","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526305835?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 12:27","pubTimestamp":1744259220,"startTime":"0","endTime":"0","summary":"四环医药(00460.HK) 公布，旗下非全资附属轩竹生物研发的创新药“吡洛西利”取得重大科研突破，其联合氟维司群治疗HR+╱HER2-晚期乳腺癌临床III期研究期中分析结果，已正式刊登于顶级期刊Nature子刊《Nature Communications》。公告指，吡洛西利联合氟维司群疗效显著。尤其是内分泌原发耐药、单纯骨转移、肝转移患者风险降低明显，并能使肿瘤缩小，缓解症状，带来生存获益。在本次研究中，吡洛西利面对人群更复杂、疾病更难治的挑战，依然获得突出生存数据。(js/j)(港股报价延迟最少十五分钟。沽空资料截至 2025-04-09 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220413154446706_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220413154446706_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1432959/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","BK1515","00460","BK1593","BK1600"],"gpt_icon":0},{"id":"2526376686","title":"先健科技盤中異動 早盤急速上漲5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526376686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526376686?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 10:25","pubTimestamp":1744251914,"startTime":"0","endTime":"0","summary":"2025年04月10日早盘10时25分，先健科技股票出现波动，股价快速拉升5.15%。截至发稿，该股报1.430港元/股，成交量667万股，换手率0.14%，振幅2.94%。先健科技股票所在的医疗设备及用品行业中，整体涨幅为0.27%。其相关个股中，康沣生物-B、健世科技-B、启明医疗-B涨幅较大，振幅较大的相关个股有康沣生物-B、堃博医疗-B、百心安-B，振幅分别为13.86%、12.37%、12.31%。结构性心脏病业务分部从事买卖、制造先天性心脏病封堵器及左心耳封堵器。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410102514a454669f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410102514a454669f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1600","01302","BK1583","BK1100"],"gpt_icon":0},{"id":"2526731613","title":"四環醫藥盤中異動 早盤股價大漲5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526731613","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526731613?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 10:04","pubTimestamp":1744250657,"startTime":"0","endTime":"0","summary":"2025年04月10日早盘10时04分，四环医药股票出现波动，股价快速上涨5.08%。截至发稿，该股报0.620港元/股，成交量1239.9万股，换手率0.13%，振幅5.08%。四环医药股票所在的药品行业中，整体涨幅为0.58%。其相关个股中，三生制药、德琪医药-B、康龙化成涨幅较大，振幅较大的相关个股有三生制药、德琪医药-B、亿胜生物科技，振幅分别为11.17%、9.36%、7.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410100417a4546199&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410100417a4546199&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1600","BK1593","00460","BK1191","BK1515"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":67,"code":"91000000","status":"200"}]}}